Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatic Cyst | 31 | 2024 | 367 | 8.920 |
Why?
|
Cytodiagnosis | 32 | 2024 | 447 | 6.630 |
Why?
|
Pancreatic Neoplasms | 66 | 2024 | 5369 | 6.250 |
Why?
|
Cyst Fluid | 14 | 2024 | 83 | 3.390 |
Why?
|
Adenocarcinoma, Mucinous | 16 | 2023 | 517 | 3.160 |
Why?
|
Pancreas | 21 | 2023 | 1691 | 2.860 |
Why?
|
Biopsy, Fine-Needle | 37 | 2024 | 1118 | 2.430 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 10 | 2019 | 194 | 2.360 |
Why?
|
Carcinoma, Pancreatic Ductal | 22 | 2023 | 1728 | 2.350 |
Why?
|
Bile Duct Neoplasms | 9 | 2022 | 605 | 2.250 |
Why?
|
Neuroendocrine Tumors | 8 | 2021 | 641 | 1.910 |
Why?
|
Biliary Tract Neoplasms | 5 | 2024 | 185 | 1.740 |
Why?
|
Pathology, Clinical | 7 | 2022 | 376 | 1.720 |
Why?
|
Cystadenoma, Serous | 6 | 2021 | 100 | 1.720 |
Why?
|
Carcinoembryonic Antigen | 12 | 2024 | 337 | 1.360 |
Why?
|
Terminology as Topic | 5 | 2023 | 1530 | 1.310 |
Why?
|
Triage | 3 | 2023 | 986 | 1.200 |
Why?
|
Cholangiocarcinoma | 4 | 2022 | 552 | 1.170 |
Why?
|
Bile Ducts | 6 | 2022 | 282 | 1.100 |
Why?
|
Biopsy, Needle | 23 | 2019 | 1626 | 1.060 |
Why?
|
Societies, Medical | 11 | 2023 | 3905 | 1.020 |
Why?
|
Diagnostic Tests, Routine | 3 | 2020 | 787 | 0.910 |
Why?
|
Biliary Tract | 3 | 2015 | 135 | 0.890 |
Why?
|
Preoperative Period | 5 | 2021 | 551 | 0.860 |
Why?
|
Adenoma, Oxyphilic | 3 | 2023 | 148 | 0.850 |
Why?
|
Cystadenocarcinoma, Mucinous | 2 | 2013 | 50 | 0.840 |
Why?
|
Endosonography | 12 | 2016 | 609 | 0.810 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2021 | 3639 | 0.810 |
Why?
|
Pancreatic Ducts | 6 | 2014 | 329 | 0.800 |
Why?
|
World Health Organization | 3 | 2024 | 1322 | 0.750 |
Why?
|
Diagnosis, Differential | 40 | 2023 | 12975 | 0.730 |
Why?
|
Cystadenoma | 3 | 2018 | 79 | 0.720 |
Why?
|
Carcinoma, Papillary | 8 | 2016 | 785 | 0.690 |
Why?
|
Duodenum | 3 | 2011 | 490 | 0.690 |
Why?
|
Cervix Uteri | 2 | 2020 | 570 | 0.690 |
Why?
|
Neoplastic Cells, Circulating | 5 | 2020 | 946 | 0.690 |
Why?
|
Uterine Cervical Diseases | 1 | 2020 | 73 | 0.690 |
Why?
|
Cystadenoma, Mucinous | 2 | 2016 | 62 | 0.630 |
Why?
|
Surgical Instruments | 2 | 2018 | 383 | 0.630 |
Why?
|
Granular Cell Tumor | 1 | 2018 | 48 | 0.620 |
Why?
|
Precancerous Conditions | 3 | 2022 | 980 | 0.620 |
Why?
|
Epithelial Cells | 5 | 2015 | 3677 | 0.600 |
Why?
|
Sensitivity and Specificity | 24 | 2021 | 14666 | 0.600 |
Why?
|
Kidney Neoplasms | 4 | 2023 | 4251 | 0.590 |
Why?
|
Antibodies | 3 | 2021 | 2418 | 0.570 |
Why?
|
Biopsy | 5 | 2023 | 6766 | 0.570 |
Why?
|
Practice Guidelines as Topic | 5 | 2016 | 7391 | 0.560 |
Why?
|
Liver Neoplasms | 7 | 2018 | 4319 | 0.550 |
Why?
|
Adenocarcinoma | 11 | 2020 | 6346 | 0.540 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2017 | 120 | 0.540 |
Why?
|
Histocytological Preparation Techniques | 1 | 2016 | 33 | 0.530 |
Why?
|
Humans | 161 | 2024 | 761572 | 0.510 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 9 | 2024 | 1745 | 0.510 |
Why?
|
Antibodies, Neoplasm | 2 | 2007 | 281 | 0.490 |
Why?
|
Aged, 80 and over | 37 | 2024 | 58986 | 0.480 |
Why?
|
Immunohistochemistry | 16 | 2020 | 11076 | 0.450 |
Why?
|
Pathology, Surgical | 4 | 2022 | 151 | 0.450 |
Why?
|
Breast | 2 | 2023 | 1967 | 0.440 |
Why?
|
Gastric Mucosa | 2 | 2007 | 604 | 0.430 |
Why?
|
Histiocytosis, Sinus | 2 | 2010 | 45 | 0.430 |
Why?
|
Pancreatitis, Chronic | 3 | 2017 | 289 | 0.410 |
Why?
|
Aged | 63 | 2024 | 169310 | 0.400 |
Why?
|
Middle Aged | 73 | 2024 | 220920 | 0.390 |
Why?
|
Guillain-Barre Syndrome | 1 | 2013 | 127 | 0.380 |
Why?
|
Dermatitis Herpetiformis | 1 | 2011 | 23 | 0.380 |
Why?
|
Lymphangioma | 1 | 2011 | 61 | 0.380 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 931 | 0.380 |
Why?
|
Mixed Tumor, Malignant | 1 | 2011 | 16 | 0.380 |
Why?
|
Dapsone | 1 | 2011 | 56 | 0.370 |
Why?
|
Methemoglobinemia | 1 | 2011 | 44 | 0.370 |
Why?
|
Goiter, Nodular | 1 | 2010 | 28 | 0.360 |
Why?
|
Antibodies, Monoclonal | 4 | 2021 | 9177 | 0.360 |
Why?
|
Carcinoma, Renal Cell | 2 | 2023 | 3165 | 0.350 |
Why?
|
Female | 89 | 2024 | 392686 | 0.350 |
Why?
|
Celiac Disease | 2 | 2011 | 821 | 0.350 |
Why?
|
Tonsillar Neoplasms | 1 | 2010 | 50 | 0.340 |
Why?
|
Herpes Simplex | 1 | 2013 | 478 | 0.330 |
Why?
|
Carcinoma, Hepatocellular | 5 | 2004 | 2297 | 0.330 |
Why?
|
Adenoma | 4 | 2017 | 2160 | 0.330 |
Why?
|
Neoplasms | 5 | 2023 | 22173 | 0.320 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2020 | 2020 | 0.310 |
Why?
|
Follow-Up Studies | 15 | 2024 | 39107 | 0.310 |
Why?
|
Smad4 Protein | 3 | 2020 | 191 | 0.310 |
Why?
|
Staining and Labeling | 3 | 2020 | 1085 | 0.310 |
Why?
|
Male | 77 | 2024 | 360842 | 0.300 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2020 | 755 | 0.290 |
Why?
|
Thyroid Nodule | 3 | 2009 | 764 | 0.290 |
Why?
|
Genes, p16 | 2 | 2020 | 160 | 0.290 |
Why?
|
Herpesvirus 1, Human | 1 | 2013 | 753 | 0.290 |
Why?
|
ras Proteins | 1 | 2012 | 1054 | 0.280 |
Why?
|
Mucins | 2 | 2009 | 568 | 0.280 |
Why?
|
Adult | 52 | 2024 | 221203 | 0.260 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2022 | 2510 | 0.260 |
Why?
|
Lung Neoplasms | 5 | 2024 | 13382 | 0.260 |
Why?
|
Bile Ducts, Intrahepatic | 3 | 2022 | 296 | 0.260 |
Why?
|
Laboratories, Hospital | 3 | 2020 | 192 | 0.250 |
Why?
|
Amylases | 2 | 2016 | 171 | 0.250 |
Why?
|
Chromogranins | 2 | 2016 | 161 | 0.250 |
Why?
|
Neoplasm Invasiveness | 6 | 2015 | 3597 | 0.240 |
Why?
|
Retrospective Studies | 26 | 2024 | 80646 | 0.230 |
Why?
|
Thyroid Gland | 2 | 2008 | 1169 | 0.230 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 2 | 2016 | 195 | 0.230 |
Why?
|
Lung Transplantation | 3 | 2024 | 1310 | 0.230 |
Why?
|
Amyloidosis | 2 | 2010 | 817 | 0.230 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3249 | 0.220 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2003 | 66 | 0.220 |
Why?
|
Pathology | 3 | 2012 | 270 | 0.220 |
Why?
|
Constriction, Pathologic | 3 | 2022 | 1096 | 0.220 |
Why?
|
Head and Neck Neoplasms | 4 | 2016 | 2895 | 0.210 |
Why?
|
Reference Standards | 3 | 2017 | 1003 | 0.210 |
Why?
|
Adenoma, Pleomorphic | 2 | 1995 | 75 | 0.210 |
Why?
|
Sampling Studies | 3 | 2013 | 615 | 0.210 |
Why?
|
Goblet Cells | 1 | 2005 | 298 | 0.200 |
Why?
|
Carcinoma, Acinar Cell | 3 | 2017 | 62 | 0.200 |
Why?
|
Parotid Neoplasms | 2 | 1995 | 157 | 0.200 |
Why?
|
Pharmacy | 1 | 2023 | 91 | 0.190 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2020 | 698 | 0.190 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2022 | 101 | 0.190 |
Why?
|
Ampulla of Vater | 2 | 2017 | 149 | 0.190 |
Why?
|
Image Cytometry | 1 | 2001 | 54 | 0.190 |
Why?
|
Sarcoma, Kaposi | 1 | 2024 | 374 | 0.180 |
Why?
|
Predictive Value of Tests | 10 | 2021 | 15266 | 0.180 |
Why?
|
Preoperative Care | 4 | 2014 | 2242 | 0.180 |
Why?
|
Needles | 2 | 2020 | 451 | 0.180 |
Why?
|
Foam Cells | 1 | 2020 | 68 | 0.170 |
Why?
|
Azo Compounds | 1 | 2020 | 117 | 0.170 |
Why?
|
Proto-Oncogene Proteins | 1 | 2012 | 4513 | 0.170 |
Why?
|
Vaginal Smears | 2 | 2002 | 499 | 0.170 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2020 | 2917 | 0.170 |
Why?
|
Growth Disorders | 1 | 2005 | 655 | 0.170 |
Why?
|
Hemangioendothelioma, Epithelioid | 1 | 2020 | 54 | 0.170 |
Why?
|
Cholangitis, Sclerosing | 1 | 2021 | 177 | 0.170 |
Why?
|
Ascitic Fluid | 1 | 2019 | 189 | 0.160 |
Why?
|
Oxygen | 1 | 2011 | 4227 | 0.160 |
Why?
|
Therapeutic Irrigation | 1 | 2020 | 292 | 0.160 |
Why?
|
Solitary Fibrous Tumors | 1 | 2020 | 67 | 0.160 |
Why?
|
Carcinoma | 4 | 2004 | 2330 | 0.160 |
Why?
|
Thyroid Neoplasms | 6 | 2009 | 2332 | 0.160 |
Why?
|
Pancreatectomy | 4 | 2021 | 811 | 0.160 |
Why?
|
Lung | 4 | 2023 | 10002 | 0.160 |
Why?
|
Prognosis | 12 | 2020 | 29629 | 0.160 |
Why?
|
Mutation | 7 | 2020 | 30054 | 0.160 |
Why?
|
Ultrasonography | 5 | 2008 | 5972 | 0.160 |
Why?
|
Laboratories | 1 | 2022 | 458 | 0.150 |
Why?
|
Nephrectomy | 1 | 2023 | 937 | 0.150 |
Why?
|
Histological Techniques | 2 | 1997 | 193 | 0.150 |
Why?
|
Reticulin | 1 | 1997 | 19 | 0.150 |
Why?
|
Neoplasm Seeding | 2 | 2014 | 85 | 0.150 |
Why?
|
Cough | 2 | 2013 | 594 | 0.150 |
Why?
|
Kidney | 2 | 2023 | 7047 | 0.150 |
Why?
|
Genes, p53 | 1 | 2020 | 712 | 0.150 |
Why?
|
DNA, Viral | 2 | 2016 | 2202 | 0.150 |
Why?
|
Flow Cytometry | 3 | 2014 | 5869 | 0.150 |
Why?
|
Body Fluids | 1 | 2019 | 320 | 0.150 |
Why?
|
Mass Screening | 1 | 2013 | 5428 | 0.150 |
Why?
|
Bronchoalveolar Lavage | 2 | 2020 | 129 | 0.150 |
Why?
|
Macrophages, Alveolar | 1 | 2020 | 412 | 0.150 |
Why?
|
Coloring Agents | 1 | 2020 | 562 | 0.150 |
Why?
|
Pancreatic Diseases | 2 | 2017 | 343 | 0.150 |
Why?
|
Pericardial Effusion | 1 | 2019 | 247 | 0.140 |
Why?
|
Autoantibodies | 2 | 2005 | 2116 | 0.140 |
Why?
|
Communicable Disease Control | 2 | 2022 | 846 | 0.140 |
Why?
|
Patient Care | 1 | 2023 | 622 | 0.140 |
Why?
|
Pleural Effusion | 1 | 2020 | 341 | 0.140 |
Why?
|
Skin | 1 | 2011 | 4484 | 0.140 |
Why?
|
Hepatocytes | 1 | 2004 | 1233 | 0.140 |
Why?
|
Epidermal Cyst | 1 | 2017 | 64 | 0.130 |
Why?
|
Splenic Diseases | 1 | 2017 | 90 | 0.130 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2011 | 3415 | 0.130 |
Why?
|
Antibody Specificity | 2 | 2019 | 1060 | 0.130 |
Why?
|
Sarcoma | 2 | 2019 | 1801 | 0.130 |
Why?
|
Reproducibility of Results | 10 | 2019 | 20099 | 0.130 |
Why?
|
Intestinal Mucosa | 1 | 2007 | 3032 | 0.130 |
Why?
|
Pelvis | 1 | 2020 | 733 | 0.130 |
Why?
|
Interferometry | 2 | 2014 | 100 | 0.130 |
Why?
|
Granuloma | 1 | 1998 | 328 | 0.130 |
Why?
|
Adolescent | 16 | 2020 | 88324 | 0.130 |
Why?
|
Carcinoma, Mucoepidermoid | 2 | 1997 | 89 | 0.130 |
Why?
|
False Negative Reactions | 3 | 2015 | 573 | 0.130 |
Why?
|
Cell Nucleus | 5 | 2020 | 2910 | 0.130 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2018 | 2827 | 0.130 |
Why?
|
Young Adult | 9 | 2024 | 59255 | 0.130 |
Why?
|
Genital Neoplasms, Female | 1 | 2020 | 532 | 0.120 |
Why?
|
Pneumonia, Viral | 1 | 2013 | 3206 | 0.120 |
Why?
|
Lymphoma | 2 | 2001 | 1901 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 10 | 2014 | 20571 | 0.120 |
Why?
|
Heavy Chain Disease | 1 | 2014 | 19 | 0.120 |
Why?
|
Workload | 1 | 2020 | 844 | 0.120 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2014 | 507 | 0.120 |
Why?
|
Sarcoidosis | 1 | 2000 | 521 | 0.120 |
Why?
|
Adenocarcinoma, Papillary | 1 | 2014 | 84 | 0.120 |
Why?
|
Costs and Cost Analysis | 1 | 2000 | 1668 | 0.120 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 3810 | 0.120 |
Why?
|
Lymphocytes | 1 | 2022 | 2612 | 0.110 |
Why?
|
Human papillomavirus 16 | 1 | 2016 | 267 | 0.110 |
Why?
|
Cohort Studies | 7 | 2020 | 41493 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 3 | 2014 | 1159 | 0.110 |
Why?
|
Research Report | 1 | 2017 | 367 | 0.110 |
Why?
|
Fasciitis | 1 | 2014 | 67 | 0.110 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2015 | 305 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 4 | 2016 | 4026 | 0.110 |
Why?
|
Cecal Diseases | 2 | 2003 | 49 | 0.110 |
Why?
|
Neoplasm Metastasis | 3 | 2004 | 4915 | 0.110 |
Why?
|
Papillomavirus Infections | 2 | 2016 | 1613 | 0.110 |
Why?
|
Ovarian Neoplasms | 2 | 2004 | 4878 | 0.100 |
Why?
|
Mammary Glands, Animal | 1 | 2014 | 273 | 0.100 |
Why?
|
Papilloma, Intraductal | 1 | 2012 | 21 | 0.100 |
Why?
|
Diagnostic Errors | 3 | 2022 | 1265 | 0.100 |
Why?
|
Observer Variation | 2 | 2020 | 2606 | 0.100 |
Why?
|
Quality Assurance, Health Care | 1 | 2022 | 2169 | 0.100 |
Why?
|
Multimedia | 1 | 2012 | 75 | 0.100 |
Why?
|
Calcinosis | 1 | 2020 | 1469 | 0.100 |
Why?
|
Neoplasm Staging | 7 | 2015 | 11121 | 0.100 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1902 | 0.100 |
Why?
|
Carcinoma, Endometrioid | 1 | 1994 | 276 | 0.100 |
Why?
|
Central Nervous System Neoplasms | 1 | 2020 | 916 | 0.100 |
Why?
|
Gastrointestinal Stromal Tumors | 2 | 2009 | 617 | 0.090 |
Why?
|
Prospective Studies | 7 | 2021 | 54426 | 0.090 |
Why?
|
Ilium | 1 | 1992 | 155 | 0.090 |
Why?
|
Immunoglobulins | 1 | 2014 | 852 | 0.090 |
Why?
|
Germinoma | 2 | 2004 | 132 | 0.090 |
Why?
|
Group Processes | 1 | 2012 | 228 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2020 | 1654 | 0.090 |
Why?
|
Algorithms | 6 | 2014 | 14032 | 0.080 |
Why?
|
Carcinoma in Situ | 2 | 2013 | 791 | 0.080 |
Why?
|
Oropharynx | 1 | 2010 | 138 | 0.080 |
Why?
|
Radiology | 1 | 2023 | 2113 | 0.080 |
Why?
|
Telepathology | 1 | 2009 | 77 | 0.080 |
Why?
|
Pancreatitis | 2 | 2007 | 1096 | 0.080 |
Why?
|
Watchful Waiting | 1 | 2013 | 491 | 0.080 |
Why?
|
Liver Diseases | 1 | 1997 | 1298 | 0.080 |
Why?
|
Leukocyte Count | 1 | 2013 | 1596 | 0.080 |
Why?
|
Hemolysis | 1 | 2011 | 415 | 0.080 |
Why?
|
DNA, Neoplasm | 2 | 2016 | 1745 | 0.080 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2010 | 695 | 0.080 |
Why?
|
Chromatin | 1 | 2020 | 2961 | 0.080 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 1991 | 262 | 0.080 |
Why?
|
Radiography | 2 | 2013 | 6965 | 0.080 |
Why?
|
Palpation | 1 | 2008 | 166 | 0.080 |
Why?
|
Tomography, Optical Coherence | 2 | 2014 | 2917 | 0.070 |
Why?
|
Patient Participation | 1 | 2017 | 1445 | 0.070 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 6075 | 0.070 |
Why?
|
Oximetry | 1 | 2011 | 459 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2013 | 2927 | 0.070 |
Why?
|
Papillomaviridae | 1 | 2013 | 1119 | 0.070 |
Why?
|
Peritoneal Neoplasms | 1 | 2014 | 711 | 0.070 |
Why?
|
Tumor Burden | 1 | 2013 | 1893 | 0.070 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 2 | 2015 | 506 | 0.070 |
Why?
|
Communication | 2 | 2022 | 3873 | 0.070 |
Why?
|
Calcium | 1 | 2020 | 5722 | 0.070 |
Why?
|
Pancreatic Pseudocyst | 1 | 2007 | 110 | 0.070 |
Why?
|
Remote Consultation | 1 | 2009 | 237 | 0.070 |
Why?
|
Loss of Heterozygosity | 1 | 2009 | 662 | 0.070 |
Why?
|
Accreditation | 1 | 2010 | 473 | 0.070 |
Why?
|
Genes, ras | 1 | 2009 | 654 | 0.070 |
Why?
|
Breast Neoplasms | 4 | 2016 | 21017 | 0.070 |
Why?
|
Cystectomy | 1 | 2010 | 634 | 0.070 |
Why?
|
Oxyphil Cells | 1 | 2006 | 56 | 0.070 |
Why?
|
Cytological Techniques | 2 | 2020 | 218 | 0.060 |
Why?
|
Education, Medical, Undergraduate | 2 | 2012 | 1070 | 0.060 |
Why?
|
Neoplasm Proteins | 2 | 2016 | 3617 | 0.060 |
Why?
|
Prednisone | 1 | 2010 | 1563 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 4016 | 0.060 |
Why?
|
Bronchogenic Cyst | 1 | 2005 | 28 | 0.060 |
Why?
|
Gastric Fundus | 1 | 2005 | 37 | 0.060 |
Why?
|
Intussusception | 1 | 2006 | 115 | 0.060 |
Why?
|
Melanosomes | 2 | 2002 | 33 | 0.060 |
Why?
|
Endometrial Neoplasms | 1 | 1994 | 1366 | 0.060 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2003 | 954 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 7 | 2014 | 36429 | 0.060 |
Why?
|
Lymph Nodes | 2 | 2010 | 3466 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5315 | 0.060 |
Why?
|
Renal Insufficiency | 1 | 2010 | 809 | 0.060 |
Why?
|
Choriocarcinoma | 1 | 2004 | 121 | 0.060 |
Why?
|
Respiratory Insufficiency | 1 | 2013 | 1230 | 0.060 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2009 | 610 | 0.060 |
Why?
|
Teaching | 1 | 2012 | 1170 | 0.060 |
Why?
|
S100 Proteins | 2 | 2002 | 218 | 0.060 |
Why?
|
Puberty, Delayed | 1 | 2005 | 121 | 0.060 |
Why?
|
Adrenal Medulla | 1 | 2003 | 56 | 0.060 |
Why?
|
Immunoenzyme Techniques | 1 | 2007 | 1705 | 0.060 |
Why?
|
Point Mutation | 1 | 2009 | 1595 | 0.060 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2010 | 783 | 0.060 |
Why?
|
False Positive Reactions | 2 | 2009 | 957 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14607 | 0.060 |
Why?
|
Stomach Diseases | 1 | 2005 | 134 | 0.060 |
Why?
|
Transglutaminases | 1 | 2005 | 197 | 0.060 |
Why?
|
Ultrasonography, Interventional | 1 | 2011 | 1496 | 0.050 |
Why?
|
Gastrointestinal Diseases | 1 | 2012 | 1200 | 0.050 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2010 | 2223 | 0.050 |
Why?
|
Keratins | 2 | 2004 | 498 | 0.050 |
Why?
|
alpha-Fetoproteins | 1 | 2004 | 223 | 0.050 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 2827 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 1995 | 4431 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2010 | 2426 | 0.050 |
Why?
|
Melanoma | 1 | 2001 | 5709 | 0.050 |
Why?
|
Consensus | 1 | 2012 | 3123 | 0.050 |
Why?
|
Cell Separation | 2 | 2020 | 1720 | 0.050 |
Why?
|
Ileal Diseases | 1 | 2002 | 68 | 0.050 |
Why?
|
Appendix | 1 | 2003 | 109 | 0.050 |
Why?
|
Lumbar Vertebrae | 1 | 1992 | 1879 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2017 | 22176 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2019 | 4811 | 0.050 |
Why?
|
Sarcoma, Clear Cell | 1 | 2002 | 72 | 0.050 |
Why?
|
Pattern Recognition, Automated | 1 | 2008 | 997 | 0.050 |
Why?
|
Pheochromocytoma | 1 | 2003 | 328 | 0.050 |
Why?
|
Radiographic Image Enhancement | 1 | 2006 | 876 | 0.050 |
Why?
|
Liposarcoma, Myxoid | 1 | 2001 | 60 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2011 | 2220 | 0.050 |
Why?
|
Gallbladder Neoplasms | 1 | 2003 | 189 | 0.050 |
Why?
|
Genomics | 1 | 2017 | 5821 | 0.050 |
Why?
|
Appendiceal Neoplasms | 1 | 2003 | 155 | 0.050 |
Why?
|
Specimen Handling | 1 | 2005 | 702 | 0.050 |
Why?
|
United States | 4 | 2023 | 72335 | 0.050 |
Why?
|
Vimentin | 1 | 2001 | 255 | 0.050 |
Why?
|
Risk Assessment | 5 | 2019 | 23996 | 0.040 |
Why?
|
Risk | 1 | 2012 | 9610 | 0.040 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2001 | 133 | 0.040 |
Why?
|
Thorax | 1 | 2023 | 555 | 0.040 |
Why?
|
Epithelioid Cells | 1 | 2020 | 60 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2014 | 9002 | 0.040 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2001 | 170 | 0.040 |
Why?
|
Surgery, Computer-Assisted | 1 | 2008 | 1007 | 0.040 |
Why?
|
STAT6 Transcription Factor | 1 | 2020 | 194 | 0.040 |
Why?
|
Adenocarcinoma, Sebaceous | 1 | 1999 | 21 | 0.040 |
Why?
|
Sebaceous Gland Neoplasms | 1 | 1999 | 40 | 0.040 |
Why?
|
Bone Neoplasms | 1 | 1992 | 2529 | 0.040 |
Why?
|
Necrosis | 1 | 2003 | 1611 | 0.040 |
Why?
|
Leiomyosarcoma | 1 | 2003 | 422 | 0.040 |
Why?
|
Exudates and Transudates | 1 | 2019 | 174 | 0.040 |
Why?
|
Diagnostic Imaging | 2 | 2012 | 3530 | 0.040 |
Why?
|
Medical Records | 1 | 2004 | 1408 | 0.040 |
Why?
|
Image Enhancement | 2 | 2008 | 2885 | 0.040 |
Why?
|
Periodicals as Topic | 1 | 2010 | 1463 | 0.040 |
Why?
|
Cardiomyopathies | 1 | 2010 | 1964 | 0.040 |
Why?
|
Body Height | 1 | 2005 | 1570 | 0.040 |
Why?
|
Testicular Neoplasms | 1 | 2004 | 799 | 0.040 |
Why?
|
Eyelid Neoplasms | 1 | 1999 | 89 | 0.040 |
Why?
|
Education, Medical | 1 | 2010 | 1725 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2000 | 362 | 0.040 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2003 | 732 | 0.040 |
Why?
|
Salivary Ducts | 1 | 1997 | 25 | 0.040 |
Why?
|
Endoscopy | 1 | 2008 | 1851 | 0.040 |
Why?
|
Pancreaticoduodenectomy | 1 | 2021 | 509 | 0.040 |
Why?
|
Stromal Cells | 1 | 2003 | 1330 | 0.040 |
Why?
|
Reference Values | 1 | 2005 | 4920 | 0.040 |
Why?
|
Chondrosarcoma | 1 | 2000 | 296 | 0.040 |
Why?
|
Urine | 1 | 1998 | 362 | 0.040 |
Why?
|
Cysts | 1 | 2002 | 681 | 0.040 |
Why?
|
Fungi | 1 | 2020 | 338 | 0.040 |
Why?
|
Intestines | 1 | 2006 | 1909 | 0.030 |
Why?
|
Anesthesia | 1 | 2008 | 1595 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6484 | 0.030 |
Why?
|
Cell Count | 1 | 2020 | 1835 | 0.030 |
Why?
|
Fixatives | 1 | 2016 | 90 | 0.030 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2016 | 109 | 0.030 |
Why?
|
Guidelines as Topic | 2 | 2014 | 1386 | 0.030 |
Why?
|
Automation, Laboratory | 1 | 2016 | 102 | 0.030 |
Why?
|
Adenoma, Bile Duct | 1 | 1995 | 29 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1997 | 1624 | 0.030 |
Why?
|
Airway Obstruction | 1 | 2020 | 661 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2016 | 302 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2016 | 241 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 3359 | 0.030 |
Why?
|
ROC Curve | 2 | 2014 | 3579 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2020 | 1125 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2122 | 0.030 |
Why?
|
Stomach Neoplasms | 1 | 2005 | 1459 | 0.030 |
Why?
|
Filtration | 1 | 2015 | 228 | 0.030 |
Why?
|
Formaldehyde | 1 | 2016 | 358 | 0.030 |
Why?
|
Oncogene Proteins, Viral | 1 | 2016 | 340 | 0.030 |
Why?
|
Cytoplasm | 2 | 2006 | 1510 | 0.030 |
Why?
|
Carcinoma, Basal Cell | 1 | 1999 | 560 | 0.030 |
Why?
|
Body Weight | 1 | 2005 | 4618 | 0.030 |
Why?
|
Abdominal Neoplasms | 1 | 1995 | 287 | 0.030 |
Why?
|
Salivary Gland Neoplasms | 1 | 1997 | 304 | 0.030 |
Why?
|
Ethanol | 1 | 2000 | 1324 | 0.030 |
Why?
|
Hysterectomy | 1 | 1998 | 857 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2005 | 2244 | 0.030 |
Why?
|
Survival Analysis | 2 | 2019 | 10090 | 0.030 |
Why?
|
Vagina | 1 | 1998 | 838 | 0.030 |
Why?
|
Histocytochemistry | 1 | 2014 | 698 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1900 | 0.020 |
Why?
|
Adipose Tissue | 2 | 2014 | 3312 | 0.020 |
Why?
|
Massachusetts | 1 | 2004 | 8830 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2015 | 1574 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 2011 | 861 | 0.020 |
Why?
|
Erythrocytes | 1 | 2020 | 2413 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2015 | 738 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2009 | 11530 | 0.020 |
Why?
|
Survival Rate | 2 | 2015 | 12725 | 0.020 |
Why?
|
Hodgkin Disease | 1 | 1998 | 1378 | 0.020 |
Why?
|
Basement Membrane | 1 | 1991 | 349 | 0.020 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 1992 | 289 | 0.020 |
Why?
|
Child | 4 | 2020 | 80156 | 0.020 |
Why?
|
Muscles | 1 | 2014 | 1576 | 0.020 |
Why?
|
Infant | 3 | 2020 | 36192 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2626 | 0.020 |
Why?
|
Bacteria | 1 | 2020 | 2199 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2014 | 1784 | 0.020 |
Why?
|
Problem-Based Learning | 1 | 2012 | 356 | 0.020 |
Why?
|
Child, Preschool | 3 | 2020 | 42230 | 0.020 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 1998 | 1405 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4111 | 0.020 |
Why?
|
Geography | 1 | 2010 | 656 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 13642 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1459 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2013 | 2850 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5247 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2014 | 1496 | 0.020 |
Why?
|
Curriculum | 2 | 2010 | 3743 | 0.020 |
Why?
|
Colloids | 1 | 2006 | 123 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5035 | 0.020 |
Why?
|
Hypothyroidism | 1 | 2011 | 668 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5769 | 0.020 |
Why?
|
Metaplasia | 1 | 2006 | 322 | 0.020 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2004 | 46 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2016 | 2986 | 0.020 |
Why?
|
Rare Diseases | 1 | 2010 | 622 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2012 | 1505 | 0.010 |
Why?
|
Laryngoscopy | 1 | 2010 | 707 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4740 | 0.010 |
Why?
|
Base Sequence | 1 | 2015 | 12441 | 0.010 |
Why?
|
Fibroblasts | 1 | 2014 | 4141 | 0.010 |
Why?
|
Program Evaluation | 1 | 2012 | 2495 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2020 | 64684 | 0.010 |
Why?
|
Educational Measurement | 1 | 2010 | 1255 | 0.010 |
Why?
|
Lymphatic Metastasis | 2 | 2002 | 2915 | 0.010 |
Why?
|
Liver | 1 | 1998 | 7529 | 0.010 |
Why?
|
Chorionic Gonadotropin | 1 | 2004 | 457 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 1779 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 11742 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8633 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2010 | 3514 | 0.010 |
Why?
|
Melanoma-Specific Antigens | 1 | 2002 | 74 | 0.010 |
Why?
|
Publishing | 1 | 2009 | 833 | 0.010 |
Why?
|
Gallbladder Diseases | 1 | 2003 | 141 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8656 | 0.010 |
Why?
|
Cell Nucleolus | 1 | 2002 | 156 | 0.010 |
Why?
|
Testis | 1 | 2004 | 794 | 0.010 |
Why?
|
Patient Care Team | 1 | 2012 | 2521 | 0.010 |
Why?
|
Cholecystectomy | 1 | 2003 | 406 | 0.010 |
Why?
|
Diverticulitis | 1 | 2003 | 185 | 0.010 |
Why?
|
Hyperplasia | 1 | 2003 | 1152 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2010 | 15843 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13510 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2003 | 727 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2014 | 4948 | 0.010 |
Why?
|
Boston | 1 | 2011 | 9326 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4244 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2010 | 2373 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12059 | 0.010 |
Why?
|
Endodermal Sinus Tumor | 1 | 1997 | 53 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 16986 | 0.010 |
Why?
|
Mice | 2 | 2014 | 81533 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12463 | 0.010 |
Why?
|
Seminoma | 1 | 1997 | 134 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2006 | 2691 | 0.010 |
Why?
|
Radiology, Interventional | 1 | 2000 | 476 | 0.010 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2002 | 874 | 0.010 |
Why?
|
Endometriosis | 1 | 2003 | 870 | 0.010 |
Why?
|
Teratoma | 1 | 1997 | 404 | 0.010 |
Why?
|
Antigens, Neoplasm | 1 | 2002 | 1993 | 0.010 |
Why?
|
Laparoscopy | 1 | 2005 | 2036 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2008 | 2578 | 0.010 |
Why?
|
Animals | 2 | 2014 | 168467 | 0.010 |
Why?
|
Logistic Models | 1 | 2006 | 13255 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 2003 | 1922 | 0.010 |
Why?
|
Chronic Disease | 1 | 2005 | 9319 | 0.010 |
Why?
|
Crohn Disease | 1 | 2003 | 2279 | 0.010 |
Why?
|
Risk Factors | 1 | 2017 | 74213 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 1998 | 2538 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2011 | 12148 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 1998 | 11122 | 0.000 |
Why?
|